help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 15, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1155
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/5/2603    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferolla, P
Right arrow Articles by Brandi, M L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferolla, P
Right arrow Articles by Brandi, M L
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Carcinoid Tumors
*Thymus Cancer

Submitted on June 22, 2004
Accepted on February 9, 2005

Thymic Neuroendocrine Carcinoma (Carcinoid) in MEN1 Syndrome: the Italian series

P Ferolla*, A Falchetti, P. Filosso, P Tomassetti, G Tamburrano, N Avenia, G Daddi, F. Puma, R Ribacchi, F Santeusanio, G Angeletti, and M L Brandi

Department of Internal Medicine and Endocrine Sciences, Thoracic Surgery, Institute of Patology University of Perugia, Perugia, Department of Internal Medicine, University of Florence, and Regional Center for Hereditary Endocrine Tumors, Florence, Department of Thoracic Surgery, University of Torino, San Giovanni Battista Hospital, Torino; Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Department of Clinical Science, Endocrine Section, University of Rome La Sapienza, Rome, Italy

* To whom correspondence should be addressed. E-mail: pferolla{at}.

Neuroendocrine tumors may occur in the setting of MEN1 syndrome. Among these a, probably underestimated, prevalence of well-differentiated neuroendocrine thymic carcinoma (carcinoid), a neoplasm characterized by a very aggressive behavior, has been described. We report the characterization of the seven Italian cases in which this association occurred among a series of 221 MEN1 patients (41 sporadic and 180 familial cases) (prevalence 3.1%). All the patients were male and 6 out of 7 (85%) were heavy smokers. No associated hormonal hyper-secretion was detected. First diagnosis was between the second and the fifth decade. Familial clusters were present in 3/7 (42.8%). No genotype-phenotype correlation was found. All the seven cases were associated with hyperparathyroidism. In one patient prophylactic thymectomy revealed a small nodular lesion suggestive of a thymic carcinoid providing evidence that preventive thymectomy might prevent further growth of an occult thymic carcinoid.

These findings confirm that thymic carcinoids are associated with a very high lethality, with a near-total prevalence in smoker males. Therefore prophylactic thymectomy should be considered at neck surgery for primary hyperparathyroidism in MEN1 male patients, especially for smokers, and, due to the frequent familial clusters distribution of this pathology, in subjects with affected relatives presenting this feature. Thus we recommend screening every patient affected with a neuroendocrine thymic neoplasm for MEN1 syndrome.


Key words: Multiple Endocrine Neoplasia • Neuroendocrine Tumors • Thymic Carcinoid • Octreoscan • MEN1 • somatostatin analogues • Octreotide • Lanreotide • Thymus




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
X.-H. Jiang, J.-L. Lu, B. Cui, Y.-J. Zhao, W.-q. Wang, J.-M. Liu, W.-Q. Fang, Y.-N. Cao, Y. Ge, C.-x. Zhang, et al.
MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1
Endocr. Relat. Cancer, December 1, 2007; 14(4): 1073 - 1079.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society